• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

群组序贯试验再探:SAS 中的简单实现。

Group sequential trials revisited: simple implementation using SAS.

机构信息

Medical and Pharmaceutical Statistics Research Unit, Department of Mathematics and Statistics, Lancaster University, UK.

出版信息

Stat Methods Med Res. 2011 Dec;20(6):635-56. doi: 10.1177/0962280210379036. Epub 2010 Sep 27.

DOI:10.1177/0962280210379036
PMID:20876163
Abstract

The methodology of group sequential trials is now well established and widely implemented. The benefits of the group sequential approach are generally acknowledged, and its use, when applied properly, is accepted by researchers and regulators. This article describes how a wide range of group sequential designs can easily be implemented using two accessible SAS functions. One of these, PROBBNRM is a standard function, while the other, SEQ, is part of the interactive matrix language of SAS, PROC IML. The account focuses on the essentials of the approach and reveals how straightforward it can be. The design of studies is described, including their evaluation in terms of the distribution of final sample size. The conduct of the interim analyses is discussed, with emphasis on the consequences of inevitable departures from the planned schedule of information accrual. The computations required for the final analysis, allowing for the sequential design, are closely related to those conducted at the design stage. Illustrative examples are given and listings of suitable of SAS code are provided.

摘要

群组序贯试验方法现在已经得到很好的确立和广泛的应用。群组序贯方法的好处被普遍认可,并且当其被正确应用时,它被研究人员和监管机构所接受。本文描述了如何使用两个易于访问的 SAS 函数轻松实现各种群组序贯设计。其中之一,PROBBNRM 是一个标准函数,而另一个,SEQ,是 SAS 的交互式矩阵语言 PROC IML 的一部分。该说明重点介绍了该方法的要点,并揭示了其简单性。描述了研究的设计,包括根据最终样本量分布对其进行评估。讨论了中期分析的进行,重点是不可避免地偏离计划信息累积进度表的后果。最终分析所需的计算,允许进行序贯设计,与设计阶段进行的计算密切相关。提供了说明性示例和适合的 SAS 代码清单。

相似文献

1
Group sequential trials revisited: simple implementation using SAS.群组序贯试验再探:SAS 中的简单实现。
Stat Methods Med Res. 2011 Dec;20(6):635-56. doi: 10.1177/0962280210379036. Epub 2010 Sep 27.
2
The future of Cochrane Neonatal.考克兰新生儿协作网的未来。
Early Hum Dev. 2020 Nov;150:105191. doi: 10.1016/j.earlhumdev.2020.105191. Epub 2020 Sep 12.
3
Exploring the benefits of adaptive sequential designs in time-to-event endpoint settings.探讨在生存时间终点设定中适应性序贯设计的优势。
Stat Med. 2011 May 20;30(11):1199-217. doi: 10.1002/sim.4156. Epub 2010 Dec 29.
4
Two-stage group-sequential designs with delayed responses - what is the point of applying corresponding methods?两阶段分组序贯设计伴有延迟反应 - 应用相应方法的意义是什么?
BMC Med Res Methodol. 2024 Oct 17;24(1):242. doi: 10.1186/s12874-024-02363-7.
5
A SAS macro for sample size adjustment and randomization test for internal pilot study.用于内部预试验样本量调整和随机化检验的SAS宏程序。
Comput Methods Programs Biomed. 2008 Apr;90(1):66-88. doi: 10.1016/j.cmpb.2007.11.016. Epub 2008 Jan 14.
6
Simple SAS macros for the calculation of exact binomial and Poisson confidence limits.用于计算精确二项式和泊松置信区间的简单SAS宏。
Comput Biol Med. 1992 Sep;22(5):351-61. doi: 10.1016/0010-4825(92)90023-g.
7
A simple and flexible graphical approach for adaptive group-sequential clinical trials.一种用于适应性成组序贯临床试验的简单灵活的图形方法。
J Biopharm Stat. 2016;26(2):202-16. doi: 10.1080/10543406.2014.972509. Epub 2014 Nov 5.
8
Computations for group sequential boundaries using the Lan-DeMets spending function method.使用Lan-DeMets消耗函数法计算组序贯界值。
Control Clin Trials. 2000 Jun;21(3):190-207. doi: 10.1016/s0197-2456(00)00057-x.
9
Sequential trials in the context of competing risks: Concepts and case study, with R and SAS code.在竞争风险背景下的序贯试验:概念和案例研究,附 R 和 SAS 代码。
Stat Med. 2019 Aug 30;38(19):3682-3702. doi: 10.1002/sim.8184. Epub 2019 May 17.
10
Optimal spending functions for asymmetric group sequential designs.非对称组序贯设计的最优花费函数
Biom J. 2007 Jun;49(3):337-45. doi: 10.1002/bimj.200510205.

引用本文的文献

1
Efficient Adaptive Designs for Clinical Trials of Interventions for COVID-19.针对COVID-19干预措施临床试验的高效自适应设计
Stat Biopharm Res. 2020 Jul 29;12(4):483-497. doi: 10.1080/19466315.2020.1790415.
2
Adding flexibility to clinical trial designs: an example-based guide to the practical use of adaptive designs.为临床试验设计增添灵活性:基于实例的适应性设计实际应用指南。
BMC Med. 2020 Nov 19;18(1):352. doi: 10.1186/s12916-020-01808-2.
3
Estimation of treatment effects following a sequential trial of multiple treatments.多种治疗方法序贯试验后的治疗效果评估。
Stat Med. 2020 May 20;39(11):1593-1609. doi: 10.1002/sim.8497. Epub 2020 Mar 23.
4
Correction: GOST: A generic ordinal sequential trial design for a treatment trial in an emerging pandemic.更正:GOST:一种用于新兴大流行中治疗试验的通用序贯试验设计。
PLoS Negl Trop Dis. 2018 Apr 13;12(4):e0006414. doi: 10.1371/journal.pntd.0006414. eCollection 2018 Apr.
5
GOST: A generic ordinal sequential trial design for a treatment trial in an emerging pandemic.GOST:一种用于新兴大流行疾病治疗试验的通用序贯试验设计。
PLoS Negl Trop Dis. 2017 Mar 9;11(3):e0005439. doi: 10.1371/journal.pntd.0005439. eCollection 2017 Mar.
6
Generalizing boundaries for triangular designs, and efficacy estimation at extended follow-ups.推广三角设计的边界,并在延长随访中进行疗效估计。
Trials. 2015 Nov 16;16:522. doi: 10.1186/s13063-015-1018-1.
7
Evaluating clinical trial designs for investigational treatments of Ebola virus disease.评估埃博拉病毒病研究性治疗的临床试验设计。
PLoS Med. 2015 Apr 14;12(4):e1001815. doi: 10.1371/journal.pmed.1001815. eCollection 2015 Apr.
8
To compare the efficacy of two kinds of Zhizhu pills in the treatment of functional dyspepsia of spleen-deficiency and qi-stagnation syndrome: a randomized group sequential comparative trial.比较两种枳术丸治疗脾虚气滞型功能性消化不良的疗效:一项随机分组序贯比较试验。
BMC Gastroenterol. 2011 Jul 15;11:81. doi: 10.1186/1471-230X-11-81.